b215a852-fd7f-59a7-829d-aac9dc49a107
at
ClaimsKG
http://data.gesis.org/claimskg/creative_work/b215a852-fd7f-59a7-829d-aac9dc49a107
Property
Value
?:
author
claimskg:
creative_work_author/5ba994ed-d774-588c-a98c-0e86b15c12e4
?:
citation
<
https://archive.is/LYmHh?
>
<
https://archive.is/Mnq6C?
>
<
https://archive.is/XGsXw?
>
<
https://archive.is/htQP1?
>
<
https://coronavirus.jhu.edu/vaccines/blog/covid-19-vaccines-are-rolling-out-should-i-be-worried?
>
<
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary-efficacy-analysis-phase-3-cove-study?
>
<
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-publication-new-england-journal-medicine?
>
<
https://ircm.qc.ca/en/news/andre-veillette-joins-government-canada-covid-19-vaccine-task-force?
>
<
https://ircm.qc.ca/en/research/immunity-and-viral-infections/molecular-oncology?
>
<
https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-17-2020-meeting-announcement?
>
<
https://www.fda.gov/advisory-committees/vaccines-and-related-biological-products-advisory-committee/2020-meeting-materials-vaccines-and-related-biological-products-advisory-committee?
>
<
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine?
>
<
https://www.fda.gov/media/144434/download?
>
<
https://www.france24.com/en/live-news/20201219-us-authorizes-moderna-as-second-covid-19-vaccine?
>
<
https://www.jhsph.edu/faculty/directory/profile/497/william-john-moss?
>
<
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377258/?
>
<
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2022483/suppl_file/nejmoa2022483_appendix.pd?
>
?:
datePublished
2020-12-11
(xsd:date)
is
?:
itemReviewed
of
claimskg:
claim_review/54acb370-3eee-518f-b26c-72c487edfba9
?:
keywords
claimskg:
keyword/76a35fde-8589-5f5f-b7ad-b8cca98db446
claimskg:
keyword/9a6224c1-a608-5ae5-b667-237ea3dedb51
?:
mentions
claimskg:
mention/4a5800e3-401d-504f-80ec-dbecda4710eb
claimskg:
mention/9d090cca-2741-50e3-8d2a-77dbf003e2fd
?:
text
21 percent of patients from the Moderna vaccine trial have experienced severe adverse events
(en)
rdf:
type
<
http://schema.org/CreativeWork
>